The Patent Finder

Novasearch AG

Also on record
Records under this name other than patents Novasearch AG holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Showing 1 to 5 of 5 · Back to Novasearch AG

PatentTitleStatus Expires Confidence
US 6,384,042Systemic Use of 5-HT3 Receptor Antagonists Against Rheumatic Inflammatory Processes
Term ended
Term ended Feb 16, 2020 · High confidence
Term endedTerm ended Feb 16, 2020High confidence
US 6,462,065Use of 5-HT(3) Receptor Antagonists for Treating Musculoeskeletal Diseases
Term ended
Term ended Feb 16, 2020 · High confidence
Term endedTerm ended Feb 16, 2020High confidence
US 7,393,857Use of 5-HT3 receptor antagonists for treating musculoskeletal diseases
Lapsed on the fee record
Ended Jul 1, 2016 · From the USPTO record
Lapsed on the fee recordEnded Jul 1, 2016From the USPTO record
US 5,773,436Use of serotonin antagonists for treating fibromyalgia
Term ended
Term ended no later than Jun 30, 2018 · Low confidence
Term endedTerm ended no later than Jun 30, 2018Low confidence
US 5,985,866Use of serotonin antagonists for treating fibromyalgia
Term ended
Term ended no later than Nov 16, 2019 · Low confidence
Term endedTerm ended no later than Nov 16, 2019Low confidence
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited